Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

12.83 +2.75 (+27.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,697,007
Open 10.43
Bid (Size) 12.65 (20)
Ask (Size) 12.83 (8)
Prev. Close 10.08
Today's Range 10.42 - 13.79
52wk Range 8.790 - 32.10
Shares Outstanding 41,969,994
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nasdaq Up Triple Digits Amid Tech Resurgence
The Nasdaq Composite Index is up 190 points as Big Tech stages a comeback following last week's selloff. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Cassava Sciences Advances Alzheimer's Drug Through High-Stakes Phase 3 Trials
Cassava Sciences' Phase 3 trials for Alzheimer's drug simufilam could change treatment standards. With trials costing millions, success could revolutionize care for millions. CEO emphasizes... 
Via Benzinga

Performance

YTD
-42.77%
-42.77%
1 Month
-35.91%
-35.91%
3 Month
-37.41%
-37.41%
6 Month
-51.22%
-51.22%
1 Year
-37.81%
-37.81%

More News

Read More
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Is MIRA Pharmaceuticals (MIRA) Stock Up 318% Today?
Via InvestorPlace
RDDT Stock Alert: Reddit Nabs New Deals with NFL, NBA
Via InvestorPlace
SAVA Stock Alert: Cassava Sciences Pops on Late-Stage Trial Update
Via InvestorPlace
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
Via Benzinga
Why Cassava Sciences Stock Is Skyrocketing Today
Via The Motley Fool
Dow Jumps 200 Points; Synchrony Financial Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Cassava Sciences Faces Leadership Shake-Up, Prioritizes Transparency And Scientific Rigor In Alzheimer's Trials
Via Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
SOUN Stock: Sports Bar Chain Rolls Out Voice Tech From SoundHound AI
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
SAVA Stock Plunges as Cassava Sciences CEO Steps Down. What to Know.
Via InvestorPlace
Crude Oil Rises 2%; Five Below Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Nasdaq Dips 300 Points; Johnson & Johnson Earnings Top Estimates
Via Benzinga
ASML Reports Q2 Results, Joins Spirit Airlines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
From Cassava Sciences, Inc.
Via GlobeNewswire
3 Healthcare Stocks to Sell in July Before They Crash & Burn
Via InvestorPlace
Top 5 Health Care Stocks That May Explode In July
Via Benzinga
3 Biotech Stocks to Sell in July Before They Crash & Burn
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Cassava Sciences Stock Is Sinking Today
Via The Motley Fool
Planet Labs Layoffs 2024: What to Know About the Latest Planet Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
Cassava Sciences Cooperates With DOJ, SEC On Controversial Alzheimer's Drug Investigation
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Are Stocks Down Today?
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.